Penn Researchers Discover New Technique to Form Human Artificial Chromosomes
Researchers at Penn led by Ben Black, PhD, the Eldridge Reeves Johnson Foundation Professor of Biochemistry and Biophysics, have found a new way to create synthetic chromosomes.
Philly Nonprofit Awarded $48 Million to Apply AI in Search for New Uses for Approved Drugs
AI based on specific algorithms will scan tens of thousands of approved medications and rare diseases to find potential matches.
Penn Leaders Featured in the Philadelphia Business Journal’s Power 100 List
PCI congratulates these Penn leaders for their inclusion in the Philadelphia Business Journal's list of "100 business leaders set to shape Philadelphia in 2024."
AInSights Uses AI for Real-time Image Analysis
Penn Medicine's AInSights is a cloud-based machine learning platform accessible by clinicians for real-time image analysis supporting multiple machine learning algorithms.
The Future Applications of Penn Medicine’s mRNA Technology
Weissman has partnered in building 18 mRNA-capable Good Manufacturing Practice (GMP) sites to date across the world.
Penn health system profits support medical research and teaching over past decade
Penn was highlighted in the Philadelphia Inquirer for investing $2 billion in profits from its health system into medical research and physician support over the past decade.
PCI Showcases Penn’s Neuroscience Innovation During JP Morgan Healthcare Conference
The program was well attended by professionals from across the globe in pharma, medtech and biotech industries and offered an incredible opportunity for networking and connection.
Penn Nobel-Prize Winners Receive Warm Welcome in Sweden
Karikó and Weissman were celebrated at several days of ceremonies and festivities in Sweden, two months after first learning the news.
Serpex Acquired by Maverix Medical
Serpex Medical leverages the power of steerable instruments to enable greater precision and access to improve the diagnosis and treatment of lung cancer.
More than 260,000 Penn Medicine patients have agreed to share their DNA for research via Penn Medicine BioBank
By obtaining samples from a wide-cross section of humanity, researchers are able to cross-reference participants’ DNA with their health records and identify genetic variants for a range of diseases.